119 related articles for article (PubMed ID: 30508644)
1. Participation of vitamin D-upregulated protein 1 (TXNIP)-ASK1-JNK1 signalosome in the enhancement of AML cell death by a post-cytotoxic differentiation regimen.
Wang X; Nachliely M; Harrison JS; Danilenko M; Studzinski GP
J Steroid Biochem Mol Biol; 2019 Mar; 187():166-173. PubMed ID: 30508644
[TBL] [Abstract][Full Text] [Related]
2. Differentiation agents increase the potential AraC therapy of AML by reactivating cell death pathways without enhancing ROS generation.
Wang X; Dawod A; Nachliely M; Harrison JS; Danilenko M; Studzinski GP
J Cell Physiol; 2020 Jan; 235(1):573-586. PubMed ID: 31245853
[TBL] [Abstract][Full Text] [Related]
3. JNK1 as a signaling node in VDR-BRAF induction of cell death in AML.
Wang X; Beute WK; Harrison JS; Studzinski GP
J Steroid Biochem Mol Biol; 2018 Mar; 177():149-154. PubMed ID: 28765039
[TBL] [Abstract][Full Text] [Related]
4. The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts.
Harrison JS; Wang X; Studzinski GP
Oncotarget; 2016 Jun; 7(24):36447-36460. PubMed ID: 27144333
[TBL] [Abstract][Full Text] [Related]
5. BRAF signals to pro-apoptotic BIM to enhance AraC cytotoxicity induced in AML cells by Vitamin D-based differentiation agents.
Wang X; Harrison JS; Studzinski GP
J Steroid Biochem Mol Biol; 2017 Oct; 173():139-147. PubMed ID: 27637326
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.
Wang X; Harrison JS; Studzinski GP
J Steroid Biochem Mol Biol; 2016 Nov; 164():72-78. PubMed ID: 26319201
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of sorafenib-mediated death of Hepatocellular carcinoma cells by Carnosic acid and Vitamin D2 analog combination.
Wu Q; Wang X; Pham K; Luna A; Studzinski GP; Liu C
J Steroid Biochem Mol Biol; 2020 Mar; 197():105524. PubMed ID: 31704246
[TBL] [Abstract][Full Text] [Related]
9. Involvement of microRNA181a in differentiation and cell cycle arrest induced by a plant-derived antioxidant carnosic acid and vitamin D analog doxercalciferol in human leukemia cells.
Duggal J; Harrison JS; Studzinski GP; Wang X
Microrna; 2012; 1(1):26-33. PubMed ID: 25048087
[TBL] [Abstract][Full Text] [Related]
10. Roles of Glutathione and AP-1 in the Enhancement of Vitamin D-Induced Differentiation by Activators of the Nrf2 Signaling Pathway in Acute Myeloid Leukemia Cells.
Jramne-Saleem Y; Danilenko M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396960
[TBL] [Abstract][Full Text] [Related]
11. n-3 Polyunsaturated fatty acids induce acute myeloid leukemia cell death associated with mitochondrial glycolytic switch and Nrf2 pathway activation.
Picou F; Debeissat C; Bourgeais J; Gallay N; Ferrié E; Foucault A; Ravalet N; Maciejewski A; Vallet N; Ducrocq E; Haddaoui L; Domenech J; Hérault O; Gyan E
Pharmacol Res; 2018 Oct; 136():45-55. PubMed ID: 30142422
[TBL] [Abstract][Full Text] [Related]
12. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
[TBL] [Abstract][Full Text] [Related]
13. Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation.
Hartman AD; Wilson-Weekes A; Suvannasankha A; Burgess GS; Phillips CA; Hincher KJ; Cripe LD; Boswell HS
Exp Hematol; 2006 Oct; 34(10):1360-76. PubMed ID: 16982329
[TBL] [Abstract][Full Text] [Related]
14. Novel analogs of 1,25-dihydroxyvitamin D
Nachliely M; Sharony E; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2016 Nov; 164():59-65. PubMed ID: 26365556
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Response of Acute Monocytic Leukemia Cells to Low-dose Cytarabine by 1,25-dihydroxyvitamin D3.
Guo H; Lin SY; Ren WX; Lei Q; Chen ZC; Zhang L; Li QB
Curr Med Sci; 2018 Feb; 38(1):35-42. PubMed ID: 30074149
[TBL] [Abstract][Full Text] [Related]
16. The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents.
Shen X; Xiong GL; Jing Y; Xiao H; Cui Y; Zhang YF; Shan YJ; Xing S; Yang M; Liu XL; Dong B; Wang LS; Luo QL; Yu ZY; Cong YW
Cancer Lett; 2015 Jan; 356(2 Pt B):686-96. PubMed ID: 25449427
[TBL] [Abstract][Full Text] [Related]
17. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
18. TLR4/NF-κB axis induces fludarabine resistance by suppressing TXNIP expression in acute myeloid leukemia cells.
Huy H; Kim TD; Kim WS; Kim DO; Byun JE; Kim MJ; Park YJ; Yoon SR; Noh JY; Lee J; Lee KH; Choi I; Jung H
Biochem Biophys Res Commun; 2018 Nov; 506(1):33-40. PubMed ID: 30336978
[TBL] [Abstract][Full Text] [Related]
19. TXNIP induces growth arrest and enhances ABT263-induced apoptosis in mixed-lineage leukemia-rearranged acute myeloid leukemia cells.
Noura M; Matsuo H; Koyama A; Adachi S; Masutani H
FEBS Open Bio; 2020 Aug; 10(8):1532-1541. PubMed ID: 32511893
[TBL] [Abstract][Full Text] [Related]
20. Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.
Österroos A; Kashif M; Haglund C; Blom K; Höglund M; Andersson C; Gustafsson MG; Eriksson A; Larsson R
Biochem Pharmacol; 2016 Oct; 118():40-49. PubMed ID: 27565890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
